益肾泄浊汤联合西药治疗糖尿病肾病Ⅲ期临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.2

基金项目:


Clinical Study on Yishen Xiezhuo Decoction Combined with Western Medicine for Diabetic Kidney Disease at Stage Ⅲ
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察益肾泄浊汤联合西药治疗糖尿病肾病(DKD) Ⅲ期肾虚湿浊证的临床疗效。方法:选 取90 例DKDⅢ期肾虚湿浊证患者,采用随机数字表法分为对照组与观察组各45 例。2 组均给予运动、饮食指 导及口服降糖药或皮下注射胰岛素治疗,对照组在此基础上给予厄贝沙坦片联合羟苯磺酸钙片治疗,观察组在 对照组基础上加用益肾泄浊汤治疗。2 组均治疗1 个月。比较2 组临床疗效,治疗前后中医证候总分、肾功能 指标及钙磷代谢指标,记录不良反应发生率。结果:治疗后,观察组总有效率93.33%,高于对照组 77.78% (P<0.05)。2 组中医证候总分均较治疗前降低(P<0.05),观察组中医证候总分低于对照组(P< 0.05)。2 组尿素氮(BUN)、血肌酐(SCr) 水平均较治疗前降低(P<0.05),肾小球滤过率(eGFR) 均较治 疗前升高(P<0.05);观察组BUN、SCr 水平均低于对照组(P<0.05),eGFR 高于对照组(P<0.05)。2 组全 段甲状旁腺激素(iPTH)、血磷水平均较治疗前降低(P<0.05),血钙水平均较治疗前升高(P<0.05);观察 组iPTH、血磷水平均低于对照组(P<0.05),血钙水平高于对照组(P<0.05)。观察组不良反应发生率 6.67%,与对照组8.89%比较,差异无统计学意义(P>0.05)。结论:益肾泄浊汤联合西药治疗DKDⅢ期肾虚 湿浊证的临床疗效优于单独使用西药治疗,可有效改善患者的肾功能及钙磷代谢水平,缓解其临床症状,且安 全性好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Yishen Xiezhuo Decoction combined with western medicine for diabetic kidney disease (DKD) at stage Ⅲ. Methods: A total of 90 cases of DKD patients at stage Ⅲ with kidney deficiency and damp-turbidity syndrome were selected and divided into the control group and the observation group according to the random number table method,with 45 cases in each group. Both groups were given exercise, diet guidance, and oral administration of hypoglycemic agents or subcutaneous injection of insulin for treatment, the control group was additionally treated with Irbesartan Tablets combined with Calcium Dobesilate Tablets,and the observation group was additionally treated with Yishen Xiezhuo Decoction based on the treatment of the control group. Both groups were treated for 1 month. The traditional Chinese medicine(TCM) syndrome scores,kidney function indexes and calcium- phosphorus metabolism indexes before and after treatment,as well as the clinical effects were compared between the two groups. The incidence of adverse reactions was recorded. Results: After treatment,the total rate of clinical effect was 93.33% in the observation group,higher than that of 77.78% in the control group (P<0.05). The total syndrome scores of TCM in the two groups were decreased when compared with those before treatment (P<0.05),and the total syndrome score of TCM in the observation group was lower than that in the control group (P<0.05). The levels of blood urea nitrogen (BUN) and serum creatinine (SCr) in the two groups were decreased when compared with those before treatment (P<0.05), and estimated glomerular filtration rates (eGFR)in the two groups were increased when compared with those before treatment (P<0.05); the levels of BUN and SCr in the observation group were lower than those in the control group (P<0.05),and eGFR in the observation group was higher than that in the control group (P<0.05). The levels of intact parathyroid hormone (iPTH) and phosphorus ions in the two groups were decreased when compared with those before treatment (P<0.05),and the calcium levels in the two groups were increased when compared with those before treatment (P<0.05); the levels of iPTH and phosphorus ions in the observation group were lower than those in the control group (P<0.05), and calcium level in the observation group was higher than that in the control group (P<0.05). The incidence of adverse reactions was 6.67% in the observation group and 8.89% in the control group, there being no significance in the difference (P>0.05). Conclusion: Yishen Xiezhuo Decoction combined with western medicine for DKD at stage Ⅲ with kidney deficiency and damp- turbidity syndrome has a better clinical effect than that of simple western medicine,which can improve kidney function and calcium-phosphorus metabolism levels of patients more effectively,and relieve their clinical symptoms,with good safety.

    参考文献
    相似文献
    引证文献
引用本文

张雅萍,刘晨.益肾泄浊汤联合西药治疗糖尿病肾病Ⅲ期临床研究[J].新中医,2023,55(20):76-80

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-27
  • 出版日期: